eShowcase: TCN e-Systems
Tool places sponsors in control of their patient recruitment programs with real-time data reporting
Tool places sponsors in control of their patient recruitment programs with real-time data reporting
BBK Worldwide (Newton, MA) has a new suite of recruitment tools that are flexible and customizable for individual trial needs. TCN e-Systems produces real-time data designed to maximize clients' recruitment programs and cut enrollment times.
The main features of TCN e-Systems include: enrollment projection modeling; real-time tracking of recruitment tactics, inquiries, and referrals; accurate measurement of site and CRO performance; and control of clinical trial costs. The solution is applicable whether sponsors want to manage and/or deploy efforts for an entire therapeutic category, a specific protocol, or a single clinical study site. TCN e-Systems is comprised of six modules: Study Forecaster, Site Organizer, Patient Generator, Study Materials & Approval Tracker, Retention & Compliance, and Study Message Center.
BBK Worldwide, (617) 630-4477, www.bbkworldwide.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
